HomeFULC • NASDAQ
add
Fulcrum Therapeutics Inc
Previous close
$6.88
Day range
$6.58 - $6.95
Year range
$2.32 - $10.13
Market cap
375.40M USD
Avg Volume
883.77K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.83M | -33.37% |
Net income | -17.30M | -131.22% |
Net profit margin | — | — |
Earnings per share | -0.28 | -132.18% |
EBITDA | -19.47M | -136.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 214.11M | -21.79% |
Total assets | 228.84M | -22.23% |
Total liabilities | 14.46M | -29.35% |
Total equity | 214.38M | — |
Shares outstanding | 54.09M | — |
Price to book | 1.74 | — |
Return on assets | -21.01% | — |
Return on capital | -21.61% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -17.30M | -131.22% |
Cash from operations | -13.82M | -123.46% |
Cash from investing | 13.93M | 211.39% |
Cash from financing | 301.00K | -20.16% |
Net change in cash | 414.00K | -99.11% |
Free cash flow | -7.71M | -120.49% |
About
Founded
2015
Website
Employees
45
